LaVoieHealthScience

Alphabetical Index | Geographical Index | Specialty Index


LaVoieHealthScience Ranked PR firm

LaVoieHealthScience

20 Park Plaza, Suite 312, Boston, MA 02116

617/374-8800

[email protected]

https://lavoiehealthscience.com
Strategic communications including public relations, investor relations and corporate communications, as well as marketing and digital communications.

Employees: 24. Founded: 2001.

Agency Statement:

(L to R) Sharon Correia, EVP and Chief Strategy Officer; James Heins, Senior Vice President & Managing Director, NY Practice, Lisa DeScenza, VP, Integrated Communications & Head, BD & Marketing; Paul Sagan, VP, IR & Corp. Comms; Donna L. LaVoie, President & CEO; Ella Deych, SVP, Finance and Chief Operations Officer; Sharon Choe, SVP & Head, Investor Outreach & Corporate Access; Douglas Russell, SVP, Client Service & PR/Media; Harriet Ullman, VP, PR & Product Communications

(L to R) Sharon Correia, EVP and Chief Strategy Officer; James Heins, Senior Vice President & Managing Director, NY Practice, Lisa DeScenza, VP, Integrated Communications & Head, BD & Marketing; Paul Sagan, VP, IR & Corp. Comms; Donna L. LaVoie, President & CEO; Ella Deych, SVP, Finance and Chief Operations Officer; Sharon Choe, SVP & Head, Investor Outreach & Corporate Access; Douglas Russell, SVP, Client Service & PR/Media; Harriet Ullman, VP, PR & Product Communications

LaVoieHealthScience advances health and science innovations through strategic communications. We offer fully integrated public relations, investor relations, marketing, and digital services and are ranked among the Top 30 independent healthcare communications agencies in the United States according to O’Dwyer’s 2022 public relations firm rankings. We are also one of Inc. 5000’s fastest-growing private companies, and Boston Business Journal’s 2022 Fast 50 representing the 50 fastest growing companies in Massachusetts. We are certified in healthcare communications compliance and serve commercial and pre-commercial clients both domestically and globally. Through our alliance with Omnicom Public Relations Group, we bring our global clients a broader set of health and science teams offering over 2,000 health experts worldwide. We are committed to serving health and science clients offering domain experience in autoimmune diseases, CAR-T, cell and gene therapy, CNS, CRISPR, immuno-oncology, lysosomal diseases, MedTech, medical devices, neurodegeneration, oncology, ophthalmology, precision medicines, rare disease, RNA, and regenerative medicine. We’ve earned our clients’ trust with 20 years in our sector, have won over 60 public relations and investor relations awards, developed over 400 communications plans, and have doubled the size of the agency since 2018.

Donna L. LaVoie, pres. & CEO; Sharon Correia, exec. VP & chief strategy officer; James Heins, sr. VP & mng. dir., NY practice; Lisa DeScenza, VP, integrated comms. & head, BD & mktg.; Paul Sagan, VP, IR & corp. comms; Ella Deych, sr. VP, finance & COO; Sharon Choe, sr. VP & head, investor outreach & corporate access; Douglas Russell, sr. VP, client service & PR/Media; Harriet Ullman, VP, PR & product comms.

58 Greenpoint Ave., Brooklyn, NY 11222
Sharon Choe
917/945-2068

Clients Include:

AC Immune SA
Biotechnology Innovation Association
Newron Pharmaceuticals SpA
Nuritas
Venthera
Celavie Biosciences
TriSalus Life Sciences
Ocugen
Omega Therapeutics
Outlook Therapeutics
Protalix Biotherapeutics
SIRION Biotech
TFF Pharmaceuticals
TG Therapeutics
Xontogeny LLC

LaVoieHealthScience in the news with O'Dwyer's:

PR is AWOL in Fight for Gun Control 

Fri., Jun. 10, 2022

...roll: Mark Read (WPP), Richard Edelman (Edelman), Garbrielle Zucker/Aaron Kwittken (KWT Global), Donna LaVoie ( LaVoieHealthScience ), Jess Fiaschette (Outside PR); Michael Kempner (MikeWorldWide), Melissa Waggener Zorkin (WE Communications), Mallory Blair...

On the Move: LaVoieHealthScience Names Bakx SVP-IR

Thu., Mar. 17, 2022

... Gemma Bakx LaVoieHealthScience  appoints Gemma Bakx as senior vice president of investor relations and financial communications. Bakx was most recently...

LHS Picks Berry to Lead Media Relations

Tue., Dec. 7, 2021

... Tony Berry UMass Memorial Health senior director, media and public relations Tony Berry joins LaVoieHealthScience  as vice president of media relations.  At UMass Memorial Health, an academic medical center and hospital...

On the Move: Rally Point Adds Hotwire Alum West

Wed., Nov. 17, 2021

...is a great mentor and advocate,” said Rally Point co-founder and managing partner John Cook. Joseph Schepers LaVoieHealthScience  appoints Joseph Schepers senior vice president of investor relations and financial communications. Schepers comes to LHS...

What PR Professionals Need To Know About ESG

Mon., Oct. 18, 2021

...DeScenza is Vice President of Integrated Communications and Head of BD and Marketing at LaVoieHealthScience ....

Events: Live Big Apple Awards Set for Sept 28

Wed., Sep. 22, 2021

...change.” Tickets for the event, as well as registration for the livestream, are available now. LaVoieHealthScience is supporting the Inaugural BioFuture Conference: Reimagine the Future of Healthcare, which will take...

Accounts in Transit: 5W Public Relations Scoops Up Skai

Fri., Jul. 2, 2021

...our media relations, and helped us connect with key audiences,” said Skai CMO Margo Kahnrose. LaVoieHealthScience  lands LexaGene Holdings, a molecular diagnostics company that develops fully automated rapid pathogen detection systems. LHS...

 Printer Friendly